Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Men with testosterone levels in the low normal range are much more likely to have diabetes than those with higher levels, independent of obesity, researchers report. "Low testosterone levels are common among men with diabetes and there is growing evidence that low testosterone may be a risk factor for developing diabetes," Dr. Elizabeth Selvin from Johns Hopkins Bloomberg School of Public Health commented to Diabetes in Control.
She and her colleagues analyzed data on 1,413 men aged 20 years or older who participated in the Third National Health and Nutrition Examination Survey. Diabetes had been diagnosed in 101 men.
In analyses adjusted for age, race and adiposity, men in the lowest tertile of free testosterone were four times more likely to have prevalent diabetes compared with men in the highest tertile (odds ratio, 4.12).
Similar results were evident for bioavailable testosterone, where the odds ratio for diabetes was 3.93 for men in the lowest tertile relative to men in the highest tertile.
The association with low free testosterone persisted even after men with clinically low total and/or free testosterone levels were excluded, suggesting, the researchers say, that the association is not entirely driven by hypogonadal men.
"Obesity affects testosterone levels; testosterone levels drop in men who are overweight or obese," Dr. Selvin pointed out. Yet, "even after accounting for the effect of obesity, low testosterone levels still appear to be an important risk factor for diabetes," she said.
These data, the researchers write, "support the hypothesis that androgens may directly influence glucose metabolism and the development of insulin resistance, independent of the effects of obesity."
Dr. Selvin added, "An important message for clinicians is that low testosterone is a common finding among men with diabetes and may lead to other clinical problems."
Diabetes Care 2007;30:234-238.
===========================
Advertisement
For the diabetic patient, it’s not the cholesterol that’s the problem. It’s the number of LDL particles, especially small LDL particles. To see the real risk, use the NMR LipoProfile(r) test, the only test that directly measures the number of LDL particles and the number of small LDL particles – the particles shown to be more predictive of CHD events than LDL-C. Click here to learn more.